Furosemide Tablet
Product Images NDC 51655-481

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 51655-481). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Furosemide Structural Formula Image (Image 03)

Furosemide Structural Formula Image (Image 03)
Chemical structure of furosemide, showing its molecular framework including a chlorinated benzene ring, sulfonamide group, carboxylic acid group, and a furan ring attached via a methylene bridge to an amine group.*
FDA Label Image

Label (51655 481 52 Rev B 06 21 Nhc)

Label (51655 481 52   Rev B 06 21 Nhc)
Furosemide Tablets USP 20 mg carton label from Northwind Health Company, LLC. The package contains 30 oral tablets, with storage instructions at 20°-25°C (68°-77°F). It provides the NDC 51655-481-52 and includes notes about keeping the product out of reach of children, storing in the original container, and protecting from light and moisture.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.